Sanofi (SNY) Goodwill & Intangibles (2009 - 2026)

Sanofi has disclosed Goodwill & Intangibles across 18 years of filings, most recently posting $80.9 billion for Q1 2026.

• Goodwill & Intangibles for Q1 2026 came in at $80.9 billion, up 20.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $80.9 billion (up 20.5% YoY), and the FY2025 annual result was $126.7 billion, up 79.64% from the prior year.
• Goodwill & Intangibles came in at $80.9 billion for Q1 2026 at Sanofi, down from $126.7 billion in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $126.7 billion in Q4 2025 to a low of $45.6 billion in Q2 2025.
• The 5-year median for Goodwill & Intangibles is $70.5 billion (2024), against an average of $71.4 billion.
• Peak annual rise in Goodwill & Intangibles reached 79.64% in 2025, while the deepest fall reached 15.45% in 2025.
• Sanofi's Goodwill & Intangibles stood at $73.0 billion in 2022, then climbed by 8.69% to $79.3 billion in 2023, then dropped by 11.07% to $70.5 billion in 2024, then soared by 79.64% to $126.7 billion in 2025, then tumbled by 36.17% to $80.9 billion in 2026.
• The last three Goodwill & Intangibles figures came in at $80.9 billion (Q1 2026), $126.7 billion (Q4 2025), and $80.5 billion (Q3 2025), per Business Quant data.